Publication
Functional diversification of the cephalopod proteome by RNA-editing
Our collaborators at UCSF have deposited a preprint on bioRxiv describing how RNA editing reshapes the cephalopod proteome. The study integrates proteomics with biochemical and cellular assays, using Tesorai to characterize thousands of recoding events across the squid proteome and validate them at the peptide level.
Read the paper: https://doi.org/10.64898/2025.12.15.694494
Read our in-depth case study on this collaboration: Revealing the Functional Landscape of RNA Editing.
Abstract
Coleoid cephalopods exhibit the highest levels of ADAR-mediated RNA editing of any known animal, yet the functional consequences of most recoding events remain largely unknown. We integrate proteomics with biochemical and cellular assays to characterize thousands of recoding events across the Doryteuthis pealeii proteome. Using quantitative and functional mass spectrometry, we show that RNA edit-driven recoding reshapes the cellular proteome to alter protein stability, subcellular localization, post-translational modifications, and enzymatic activity. Recoding can regulate post-translational modifications through their creation or ablation, and this has direct effects on protein function and protein-protein interactions. Recoding of the E3 ligase MARCHF5 drives widespread changes in substrate ubiquitylation and perturbs mitochondrial homeostasis, illustrating how RNA editing can influence organelle function. These data provide the first proteome-scale view of how extensive RNA recoding diversifies protein function in coleoid cephalopods and offers a new framework for understanding how RNA-level plasticity shapes protein function and cellular physiology.
Explore more resources

Publications
Single-cell foundation models benefit from cross-modal training: adding proteomics data beats parameter scaling
Fine-tuning a single-cell foundation model on proteomics data matches or beats scaling to models over 40x larger — showing multimodal training can outperform parameter scaling alone.

Building a Pan-Cancer Atlas of Therapeutic T Cell Targets
How NYU researchers used large-scale immunopeptidomics and AI-enabled peptide identification to identify 28,446 tumor-specific antigens and accelerate therapeutic target discovery.
